SEER Stock Summary and Trading Ideas (Seer - Class A | NASDAQ:SEER)

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Seer - Class A trades on the NASDAQ stock market under the symbol SEER.

As of February 28, 2025, SEER stock price declined to $2.10 with 525,002 million shares trading.

SEER has a market cap of $123.83 million. This is considered a Micro Cap stock.

Last quarter Seer - Class A reported $4 million in Revenue and -$.37 earnings per share. This beat revenue expectation by $50,000 and exceeded earnings estimates by $.02.

In the last 3 years, SEER traded as high as $16.53 and as low as $1.46.

The top ETF exchange traded funds that SEER belongs to (by Net Assets): VTI, VXF, PRFZ, IWC, AVSC.

SEER has underperformed the market in the last year with a price return of +16.7% while the SPY ETF gained +18.8%. SEER has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.0% and -9.1%, respectively, while the SPY returned -0.4% and -2.5%, respectively.

SEER support price is $2.14 and resistance is $2.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SEER shares will trade within this expected range on the day.